The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, S.
Right arrow Articles by Kadesch, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, S.
Right arrow Articles by Kadesch, T.

The Journal of Immunology, Vol 157, Issue 8 3491-3498, Copyright © 1996 by American Association of Immunologists


ARTICLES

HMG box-activating factors 1 and 2, two HMG box transcription factors that bind the human Ig heavy chain enhancer

S Stevens, P Ordentlich, R Sen and T Kadesch
Department of Genetics and Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

We present the isolation of two cDNAs that encode distinct, yet related, proteins that bind the HE2 region of the human Ig heavy chain (IgH) enhancer. Designated HMG box-activating factors (HAF) 1 and 2, the two proteins are new members of the HMG box family of DNA binding proteins. Both are potent transcription activators when expressed 1) as GAL4 fusions targeted to promoters containing GAL4 operators, or 2) as intact proteins targeted to minimal promoters containing binding sites derived from the IgH enhancer. HAF-1 and HAF-2 mRNAs are apparently expressed in both B cells and non-B cells. However, activity generated by the isolated HE2 region in B cells is dependent on both an intact HAF-1/HAF-2 binding site and at least one additional site that has been reported previously to bind a B cell-restricted protein. Our results suggest a collaborative role for either or both HAF-1 and HAF-2 in establishing the B cell activity of the human IgH enhancer.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
D. A. Ross and T. Kadesch
The Notch Intracellular Domain Can Function as a Coactivator for LEF-1
Mol. Cell. Biol., November 15, 2001; 21(22): 7537 - 7544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Mundt, I. C. Nicholson, X. Zou, A. V. Popov, C. Ayling, and M. Bruggemann
Novel Control Motif Cluster in the IgH {{delta}}-{{gamma}}3 Interval Exhibits B Cell-Specific Enhancer Function in Early Development
J. Immunol., March 1, 2001; 166(5): 3315 - 3323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. T. Lewis, A. Andreucci, and B. S. Nikolajczyk
PU.1-mediated Transcription Is Enhanced by HMG-I(Y)-dependent Structural Mechanisms
J. Biol. Chem., March 16, 2001; 276(12): 9550 - 9557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.